HUGE News and Press, FSD Pharma Inc. From 03/15/22

Research report reviews FSD Pharma’s drug development pipeline and operational milestones FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a life sciences holding company dedicated to build...

VANCOUVER, British Columbia, Feb. 28, 2022 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, has entered into a firm agreement in connection with the sale of its 64.43-ac...

FSD Pharma (NASDAQ:HUGE) has signed a deal to sell its former cannabis processing facility in Cobourg, Ontario for C$16.5M in cash, including a C$660,000 deposit. The transaction will close on May 31, 2022. The purchaser remains undisclosed. The facility covers 64.43 acres. Shares are up 5.11...

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today that it has entered into a firm agreement in...

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) , a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, today announced the launch of its newly designed website . According to the update, the new site conveys the company’s emerging posit...

New Website Shares FSD’s Unique Drug Pipeline and Vision to Improve the Quality of Life for Patients Suffering from Brain & Inflammatory Disorders FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ...

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, has announced that a member of its Research and Clinical Advisory Board has been appointed to the Order of Canada. According to the announce...

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, warmly congratulates Eleanor N. Fish, Ph.D., a member of its Research an...

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) , a life-sciences holding company dedicated to building a portfolio of assets and biotech solutions, will be involved in this month’s H.C. Wainwright Bioconnect Conference. The three-day conference is scheduled for Jan. 10–13, ...

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today that Anthony Durkacz, Interim CEO of FSD Pha...